# Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study

> **NCT03364725** · PHASE4 · UNKNOWN · sponsor: **Id Care** · enrollment: 30 (estimated)

## Conditions studied

- Hepatitis C
- Addict Heroin

## Interventions

- **DRUG:** Glecaprevir-pibrentasvir

## Key facts

- **NCT ID:** NCT03364725
- **Lead sponsor:** Id Care
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-15
- **Primary completion:** 2018-09-01
- **Final completion:** 2019-03-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03364725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03364725, "Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03364725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*